Tel:+86-21-51950625 51950635
Email us at sales@koutingchina.com
   
Products
Salmeterol 
2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino] ethyl]-phenol
(CAS 89365-50-4)
Description:

Salmeterol is a long-acting beta2-adrenergic receptor (beta 2AR) agonist used clinically to treat asthma.
Target: beta2-Adrenergic Receptor
Salmeterol is a long-acting beta2-adrenergic receptor agonist drug that is prescribed for the treatment of asthma and chronic obstructive pulmonary disease (COPD). salmeterol also binds with very high affinity at a second site, termed the "exosite", and that this exosite contributes to the long duration of action of salmeterol.

 

Product No. KT20378 
Product Name Salmeterol 
Synonyms Serevent; GR33343X
Formal Name 2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino] ethyl]-phenol
CAS Number 89365-50-4
Molecular Formula C25H37NO4
Formula Weight 415.57
Formulation A crystalline solid
Purity 98%min
Stability 2 years
Storage -20°C
Shipping USD45 for Europe and USA. No shipping charge once amount reach USD500
Quality Control HNMR,CNMR,LCMS,HPLC,IR,etc.
Price & Availability In Stock. Price Negotiated.
 
Not found? Pls contact with us for sourcing service.
Our contact email:sales@koutingchina.com
 
 
 
 
Related Products:

Adrenergic Receptor
Salbutamol hemisulfate
Salmefamol
Salmeterol xinafoate
Scopine
Silodosin
Sotalol hydrochloride
Synephrine hydrochloride
Tamsulosin
Tapentadol hydrochloride
Terazosin
Tetrahydrozoline hydrochloride
Tizanidine
Tolazoline
UK 14,304
Urapidil hydrochloride
Vilanterol
Xylazine
Xylometazoline hydrochloride

Order the product  * is required
Product:*
Your Name:*
Your Company:*
Add:
Tel:
Fax:
Web:
E-Mail:*
Your Demand :*

Products are for research use only. Not for human use. We do not sell to patients.
Copyrigh ©2009,China Kouting Group Limited All Rights Reserved. Supported by hxchem.net


products
Customer Service
Why Choose Us?
How to Order
How to Ship
How to Return
Frequently Asked Questions
Terms and Conditions
Email:sales@koutingchina.com
Skype: Notice